Researchers have been excited about Retatrutide , a novel dual treatment showing significant outcomes in clinical trials for size management. It functions by impacting both hormones : GLP-1 and GIP, that , when activated , help influence cravings and improve energy expenditure . Initial reports demonstrate considerable body reduction and potential